Characterization of bevacizumab dose response relationship in U87 brain tumors using magnetic resonance imaging measures of enhancing tumor volume and relative cerebral blood volume.

Pechman KR, Donohoe DL, Bedekar DP, Kurpad SN, Hoffmann RG, Schmainda KM
J Neurooncol. 2011 105 (2): 233-9

PMID: 21533524 · PMCID: PMC4323180 · DOI:10.1007/s11060-011-0591-8

MeSH Terms (16)

Angiogenesis Inhibitors Animals Antibodies, Monoclonal, Humanized Bevacizumab Blood Volume Brain Neoplasms Contrast Media Dose-Response Relationship, Drug Gadolinium DTPA Glioblastoma Humans Magnetic Resonance Imaging Male Rats Tumor Burden Tumor Cells, Cultured

Connections (1)

This publication is referenced by other Labnodes entities: